Dashboard
Manage Tickers

AIM AIM ImmunoTech Inc.

NYSE aimimmuno.com


$ 1.45 $ 0.00 (0 %)    

Monday, 17-Nov-2025 15:32:45 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 601.61 $ -4.52 (-0.75 %)
DIA $ 465.68 $ -5.27 (-1.12 %)
SPY $ 664.21 $ -5.52 (-0.82 %)
TLT $ 89.13 $ 0.04 (0.05 %)
GLD $ 370.70 $ -3.33 (-0.89 %)
$ 1.41
$ 1.44
$ 1.44 x 100
$ 1.46 x 136
$ 1.44 - $ 1.45
$ 0.06 - $ 20.35
39,305
na
3.82M
$ -1.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-17-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 03-30-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-17-2021 03-31-2021 10-Q
20 03-31-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-30-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 03-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
11/17/2025 21:07:48

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/11/2025 21:07:32

aim-immunotech-presents-data-from-phase-2-advanced-recurrent-ovarian-cancer-clinical-trial-across-27-participants
AIM ImmunoTech Presents Data From Phase 2 ...
11/10/2025 14:01:25

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today detailed a recent abstract containing data from t...

aim-immunotech-says-data-from-completed-phase-2-cisplatin-resistant-advanced-recurrent-ovarian-cancer-clinical-study-utilizing-ampligen-accepted-in-late-breaking-abstract-at-annual-sitc-meeting
AIM ImmunoTech Says Data From Completed Ph...
11/04/2025 14:08:37

aim-immunotech-granted-european-patent-for-ampligen-in-long-covid-treatment
AIM ImmunoTech Granted European Patent For...
11/03/2025 13:57:02

ascendiant-capital-maintains-buy-on-aim-immunotech-lowers-price-target-to-24
Ascendiant Capital Maintains Buy on AIM Im...
10/03/2025 10:19:56

Ascendiant Capital analyst Edward Woo maintains AIM ImmunoTech (AMEX:AIM) with a Buy and lowers the price target from $150 t...

aim-immunotech-secures-japanese-patent-for-ampligen-in-combination-with-checkpoint-inhibitors-for-the-treatment-of-cancer
AIM ImmunoTech Secures Japanese Patent For...
09/25/2025 12:46:47

aim-immunotech-has-been-granted-european-patent-number-ep4096675-titled-compositions-for-treating-long-covid
AIM ImmunoTech Has Been Granted European P...
09/22/2025 19:58:47

https://register.epo.org/application?number=EP21818146

aim-immunotech-says-jitc-publishes-new-peer-reviewed-article-providing-evidence-of-combination-effect-of-aims-drug-ampligen-and-interferon-alpha-on-tumor-growth-and-subsequent-subject-survival
AIM ImmunoTech Says JITC Publishes New Pee...
09/22/2025 13:05:11

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that the Journal for ImmunoTherapy of C...

aim-immunotech-q2-eps-368-beats-800-estimate-sales-2500k-miss-10000k-estimate
AIM ImmunoTech Q2 EPS $(3.68) Beats $(8.00...
08/15/2025 13:11:57

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(3.68) per share which beat the analyst consensus estimate of $(8.00) b...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

uncovering-potential-aim-immunotechs-earnings-preview
Uncovering Potential: AIM ImmunoTech's Ear...
08/13/2025 16:01:47

aim-immunotech-announces-that-its-drug-ampligen-will-be-featured-in-four-presentations-at-upcoming-5th-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care-in-warsaw-poland
Aim Immunotech Announces That Its Drug Amp...
08/06/2025 13:04:59

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that the strong clinical successes in o...

aim-immunotech-announces-company-update-including-mid-year-report-of-ampligen-in-combination-with-astrazenecas-imfinzi-for-treatment-of-pancreatic-cancer-demonstrating-signs-of-both-no-significant-toxicity-and-superior-pfs-and-oscompany-also-bolstered-cash-position-to-fund-operations-for-12-months
AIM ImmunoTech Announces Company Update In...
08/04/2025 13:06:24

Primary focus on pancreatic cancerMid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca's Imfinzi® (d...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

crude-oil-gains-over-1-unitedhealth-earnings-miss-views
Crude Oil Gains Over 1%; UnitedHealth Earn...
07/29/2025 16:53:28

us-stocks-mixed-procter--gamble-posts-upbeat-earnings
US Stocks Mixed; Procter & Gamble Posts Up...
07/29/2025 14:13:18

aim-immunotech-announces-pricing-of-2m-shares-class-e-warrants-and-class-f-warrants-at-combined-public-offering-price-gross-proceeds-8m
AIM ImmunoTech Announces Pricing Of 2M Sha...
07/29/2025 13:01:57

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 12:07:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION